Colorectal Cancer Dataset in Xijing Hospital From 2011
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorXijing Hospital
About this trial
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Eligibility criteria
Qualifiers
1. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome;
2. Visit our center with complete medical records and pathological information;
3. Colorectal cancer patients diagnosed between 2013 and 2023.
Disqualifiers
1. The patient has other colorectal malignancies other than adenocarcinoma;
2. Malignant tumors adjacent to organs invading the colon and rectum;
3. Malignant tumors from distant organs metastasize to the colon and rectum;
4. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
40,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov